HomeGroupsTalkMoreZeitgeist
Search Site
This site uses cookies to deliver our services, improve performance, for analytics, and (if not signed in) for advertising. By using LibraryThing you acknowledge that you have read and understand our Terms of Service and Privacy Policy. Your use of the site and services is subject to these policies and terms.

Results from Google Books

Click on a thumbnail to go to Google Books.

Loading...

Bad Blood: Secrets and Lies in a Silicon Valley Startup (2018)

by John Carreyrou

Other authors: See the other authors section.

MembersReviewsPopularityAverage ratingMentions
2,5151725,576 (4.31)93
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--… (more)
Loading...

Sign up for LibraryThing to find out whether you'll like this book.

No current Talk conversations about this book.

» See also 93 mentions

English (170)  Swedish (1)  All languages (171)
Showing 1-5 of 170 (next | show all)
One of the best investigative pieces I've ever read - and also, by the nature of the case, horrifying.
This book deals with Theranos, the famous Silicon Valley unicorn (a term coined for a tech startup which is valued at more than $1 billion) and its neurotic founder, Elizabeth Holmes and her equally neurotic boyfriend, Sunny Balwani.
Many people have heard that Theranos has had shady dealings (myself included), but how shady they were is revealed by this book - a treatise on Theranos spanning from its foundation till its demise (of which the author was the main catalyst). The amount of laws and regulations that the startup flouted is staggering in itself. But what is more staggering is that the premise on which Theranos was founded (that hundreds of blood tests could be performed on a tincture of blood nipped from your index finger) and which gave Holmes a personal valuation in excess of $5.5 billion, was all a hoax. How this hoax came about, who all were wittingly (and unwittingly) involved in the hoax, and how the hoax could have led about to hundreds of deaths, forms the basis of the investigative novel.
On reading this book, one can easily understand how Carreyrou has won the Pulitzer Prize twice - his treatment is precise and cutting, and very easy to decipher and absorb - even medical laymen like me will have a ton to draw from the book, as is the book's intention.
TL;DR - roller-coaster work spanning the rise and fall of a Silicon Valley startup that got too ambitious for its own good, and in sight of its goal, flouted everything there was to flout. A dense but fulfilling read. ( )
  SidKhanooja | Sep 1, 2023 |
I read this book very slowly, this was mainly because Theranos had a habit of constantly firing people and I kept forgetting who each name referred to. The book flipped between timelines a little bit and there were a few times that I had trouble following. Other than that, this is an interesting book about a woman who wanted to be the next Jobs or Gates and ended up defrauding many influential Americans. I feel bad for anyone that received a false blood test on one of her devices.

As a side note: there is a trial set to happen in October 2020. I look forward to seeing what happens. ( )
  CaitlinDaugherty | Aug 28, 2023 |
I read this book very slowly, this was mainly because Theranos had a habit of constantly firing people and I kept forgetting who each name referred to. The book flipped between timelines a little bit and there were a few times that I had trouble following. Other than that, this is an interesting book about a woman who wanted to be the next Jobs or Gates and ended up defrauding many influential Americans. I feel bad for anyone that received a false blood test on one of her devices.

As a side note: there is a trial set to happen in October 2020. I look forward to seeing what happens. ( )
  CaitlinDaugherty | Aug 28, 2023 |
The Theranos story is so fascinating. Carreyrou paces the book evenly, slowly building his case. I borrowed this from a clinical chemist who plays (per him) a bit role in the story, appearing in a couple sentences within the book. When I returned his copy, the two of us sat in his office just marveling at how things progressed so far. Within my own little clinical chemistry domain, CLIA looms like a Greek god -- all-powerful and all-knowing. Should we accidentally make a typo in our data, CLIA will send bolts of lightning to destroy us. The idea that a lab somehow became CLIA-certified with such significant variance in their data even before the straight-out fraud is almost unbelievable.

In addition, this seems like any doctor in their right mind would know what to make of Theranos. My best friend who works with silicon valley startups asked me about it several years ago, when I was still in residency, and I told her that the problem with capillary draws was hemolysis (blood cells splitting) and that you could never get some accurate results do that - and that's baked in to the blood draw, before you even get to the machinery. Any doctor worth their salt knows this.

So this is an almost fantastical story about how someone by force of personality alone paraded out technology that everyone knew was impossible, and somehow, without ever really inventing anything became a billionaire running laboratory testing in clinical labs on patients. It's pretty serious and scary stuff.

While reading it, I couldn't help but be amazed by the number of smart, well-educated people who were at least temporarily a party to this, often bullied by fancy lawyers and nondisclosure agreements. I think there's a lot here about how much the assumptions of civil society are really what keep us in check more so than institutions like CLIA or CAP. Once someone starts operating in bad faith, it's pretty scary how far they can get. On the other hand, Theranos was pretty much brought down by Carreyrou assisted by a pair of early-twenty-somethings who felt they had to speak out. So I think there's also a lot here about the importance of protecting whistle-blowers and the media. ( )
  settingshadow | Aug 19, 2023 |
Audiobook. ( )
  kylecarroll | Jul 8, 2023 |
Showing 1-5 of 170 (next | show all)
The author’s description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist; Carreyrou wisely lets the evidence speak for itself. As presented here, Holmes harbored delusions of grandeur but couldn’t cope with the messy realities of bioengineering. Swathed in her own reality distortion field, she dressed in black turtlenecks to emulate her idol Jobs and preached that the Theranos device was “the most important thing humanity has ever built.” Employees were discouraged from questioning this cultish orthodoxy by her “ruthlessness” and her “culture of fear.” Secrecy was obsessive. Labs and doors were equipped with fingerprint scanners.
 

» Add other authors

Author nameRoleType of authorWork?Status
John Carreyrouprimary authorall editionscalculated
Damron, WillNarratorsecondary authorsome editionsconfirmed
You must log in to edit Common Knowledge data.
For more help see the Common Knowledge help page.
Canonical title
Original title
Alternative titles
Original publication date
People/Characters
Important places
Important events
Related movies
Awards and honors
Epigraph
Dedication
For Molly, Sebastian, Jack, and Francesca
First words
Tim Kemp had good news for his team.
Quotations
Last words
(Click to show. Warning: May contain spoilers.)
Disambiguation notice
Publisher's editors
Blurbers
Original language
Canonical DDC/MDS
Canonical LCC

References to this work on external resources.

Wikipedia in English

None

"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--

No library descriptions found.

Book description
Haiku summary

Popular covers

Quick Links

Rating

Average: (4.31)
0.5
1 10
1.5
2 6
2.5 1
3 77
3.5 31
4 309
4.5 69
5 373

Is this you?

Become a LibraryThing Author.

 

About | Contact | Privacy/Terms | Help/FAQs | Blog | Store | APIs | TinyCat | Legacy Libraries | Early Reviewers | Common Knowledge | 195,038,037 books! | Top bar: Always visible